There will be folks out there who think a delay in finalising the trial protocol is a setback.
They still need to revise it and then go back to the FDA for approval. But I think we knew this already so its not actually news.
- Forums
- ASX - By Stock
- PNV
- Ann: FDA feedback on Pivotal Protocol
PNV
polynovo limited
Add to My Watchlist
3.07%
!
$1.26

Ann: FDA feedback on Pivotal Protocol, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.26 |
Change
0.038(3.07%) |
Mkt cap ! $863.5M |
Open | High | Low | Value | Volume |
$1.22 | $1.26 | $1.20 | $1.409M | 1.141M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
29 | 25888 | $1.26 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.26 | 39260 | 33 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
34 | 29864 | 1.255 |
26 | 18616 | 1.250 |
14 | 94379 | 1.245 |
18 | 182355 | 1.240 |
10 | 21076 | 1.235 |
Price($) | Vol. | No. |
---|---|---|
1.260 | 31565 | 31 |
1.265 | 325848 | 19 |
1.270 | 93070 | 15 |
1.275 | 34548 | 9 |
1.280 | 182365 | 8 |
Last trade - 14.20pm 18/07/2025 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |